NSA, a leader in providing premier neurohistologic services and products, announced today the launch of their newest division, the Neurotoxicity Testing Center (NTC). The NTC will enhance pharmaceutical and chemical research and development efforts by providing turn-key evaluation services to detect neurotoxicity in new drug candidates, early in the drug development process. The same safety assessment strategy is applicable to environmental compounds.
